SCHEMBL14966740

SCHEMBL14966740

Cc1cc(C=Cc2ccccc2)ccc1C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.47
TTR P02766 2/20 0.45
ALOX5 P09917 1/20 0.45
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
PTPN1 P18031 2/20 0.44
HNF4A P41235 1/20 0.44
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
HSD17B10 Q99714 1/20 0.41
HDAC1 Q13547 1/20 0.41
PPARA Q07869 2/20 0.40
TUBB1 Q9H4B7 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
SRD5A1 P18405 1/20 0.39
SRD5A2 P31213 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL360471 0.82 ALDH1A1 (0.42) PTGS2
SCHEMBL14967314 0.82 HDAC1 (0.51) PTPN1CYP2C19HSD17B10HDAC1PPARA
SCHEMBL14967548 0.82 HDAC1 (0.51) PTPN1CYP2C19HSD17B10HDAC1PPARA
SCHEMBL9805467 0.82 HDAC1 (0.51) PTPN1CYP2C19HSD17B10HDAC1PPARA
SCHEMBL19823831 0.81 MCL1 (0.38) CYP2C19
SCHEMBL2273070 0.80 NFE2L2 (0.43) NFE2L2TTRPTPN1HNF4ATUBB1
SCHEMBL2273076 0.80 NFE2L2 (0.43) NFE2L2TTRPTPN1HNF4ATUBB1
SCHEMBL2011458 0.78 KMT2A (0.40)
SCHEMBL11960797 0.78 KMT2A (0.40)
SCHEMBL29926471 0.78 RXRB (0.48) HNF4AHDAC1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780014-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2014-09-24 EP disclosed
WO-2013075083-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2013-05-23 WO disclosed